Curapel Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $743K
Latest Deal Amount
  • Investors
  • 5

Curapel General Information


Developer of specialty pharmaceutical products intended for the treatment of common skin conditions. The company's healthcare process develops oral and cream-based medicinal products for the treatment of conditions like skin pigmentation, eczema, atopic dermatitis, lightening and psoriasis, enabling the medical community and patients to meet and resolve unmet clinical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Personal Products
Drug Discovery
Primary Office
  • Stuart House
  • Chepstow NP16 5HH
  • Wales, United Kingdom
+44 07866 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Curapel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Mar-2020 $743K 00.000 00.000 Completed Generating Revenue
2. Angel (individual) 14-Jun-2014 00000 00000 00.000 Completed Startup
1. Grant $36.2K Completed Startup
To view Curapel’s complete valuation and funding history, request access »

Curapel Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pref 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Curapel’s complete cap table history, request access »

Curapel Executive Team (4)

Name Title Board Seat Contact Info
Peter Luebcke Ph.D Chief Education Officer
Neil Gibbs Ph.D Co-Founder, Chief Scientific Officer & Board Member
Alan Williams Finance Director
To view Curapel’s complete executive team members history, request access »

Curapel Board Members (2)

Name Representing Role Since
Neil Gibbs Ph.D Curapel Co-Founder, Chief Scientific Officer & Board Member 000 0000
Terry Sadler Self Chairman 000 0000
To view Curapel’s complete board members history, request access »

Curapel Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Development Bank of Wales Venture Capital Minority 000 0000 000000 0
Meltwind Venture Capital Minority 000 0000 000000 0
Lancaster Capital Angel Group Minority 000 0000 000000 0
Biotechnology and Biological Science Research Council Limited Partner 000 0000 000000 0
University of Manchester Intellectual Property Other 000 0000 000000 0
To view Curapel’s complete investors history, request access »